http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Cisplatin 내성 난소암 세포주에서 Cisplatin 처리 후 p53, p16, PTEN, c-myc 유전자의 발현
박현태 ( Park Hyeon Tae ),김상배 ( Kim Sang Bae ),이용호 ( Lee Yong Ho ),이낙우 ( Lee Nag U ),이규완 ( Lee Gyu Wan ),김미혜 ( Kim Mi Hye ),김영태 ( Kim Yeong Tae ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.7
Objective : The chemotherapeutic agent Cisplatin (cis-diammminedichloroplatinum (Ⅱ)) is particularly effective against ovarian carcinoma, however, its clinical success is limited by recurrent drug resistant tumors. It is mandatory to reveal the mechanism of cisplatin resistance for the ovarian cancer treatment or prognosis. This study assessed the expression of p53, p16, PTEN, and c-myc genes with cisplatin treatment in human ovarian cancer cell lines; cisplatin-sensitive (A2780) and cisplatin-resistan (A2780/CP70) ovarian cancer cell line to elucidate the mechanism of cisplatin resistance. Methods : Cytotoxic assay for cisplatin was performed in cisplatin-sensitive ovarian cancer cell line, A2780 and cisplatin-resistant ovarian cancer cell line, A2780/CP70. After cisplatin treatment, expression of p53, p16, PTEN, c-myc was analyzed by Western blot analysis. Results : PTEN expression was significantly about 30% higher in A2780 than in A2780/CP70. p16 expression was defective in both cell lines. p53 and c-myc expression was no difference in cancer cell lines. After cisplatin treatment, the expression of p53, PTEN, c-myc genes increased 2-3 times in both cell lines. Conclusion : Relatively lower expression of PTEN was detected in A2780/CP70 suggesting that PTEN expression might play a role in the development of cisplatin resistance in ovarian cancer cell line, A2780/CP70.